# Editas Medicine, Inc.: Form 8-K, filed Mar 7, 2017

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2017-03-07
- Accepted by EDGAR: Mar 7, 2017, 16:06 ET
- Period: 2017-03-07
- Accession: 0001558370-17-001412
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000155837017001412/g8k-2016earningspressrelease.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000155837017001412/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000155837017001412/g8k-2016earningspressrelease.htm

Filed Mar 7, 2017.
Source: SEC EDGAR, the filing index for accession 0001558370-17-001412. Last ingested by Listed: Nov 9, 2026, 17:25 ET. No prices; not investment advice.